Neutrophils are required for the DNA synthetic response of human lymphocytes to mevalonic acid: evidence suggesting that a nonsterol product of mevalonate is involved.
- 1 May 1982
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 79 (9) , 3028-3032
- https://doi.org/10.1073/pnas.79.9.3028
Abstract
Human peripheral blood lymphocytes, in the presence of human neutrophils, initiate DNA synthesis and cell cycling when exposed to mevalonic acid. The ability of lymphocytes to respond in this manner is a radiosensitive property of cells, whereas the help provided by neutrophils is maintained despite their exposure to x-irradiation. Other organic acid anions, including precursors of mevalonic acid biosynthesis and a variety of products of mevalonate metabolism, fail to initiate DNA synthesis when added to human lymphocytes. Because only the metabolically active R(--) enantiomer of mevalonic acid initiates lymphocyte DNA synthesis, we presume that physiological pathways of mevalonate metabolism are involved. The response to mevalonic acid of ML-236B (compactin)-inhibited lymphocytes is increased, and the threshold concentration of meyalonate at which lymphocyte DNA synthesis first appears is decreased, when the cells are cultured in lipoprotein-containing (as opposed to lipoprotein-depleted) medium. The response to mevalonic acid of lymphocytes cultured in lipoprotein-depleted medium can be enhanced by addition to the cultures of low density lipoprotein but not by addition of high density lipoprotein. Based upon the flux diversion hypothesis of mevalonate metabolism, these observations suggest that a nonsterol product of mevalonate metabolism may be responsible for the initiation of lymphocyte DNA synthesis by mevalonic acid.This publication has 14 references indexed in Scilit:
- Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor.Journal of Biological Chemistry, 1980
- Inhibition of human lymphocyte transformation by oxygenated sterol compoundsCellular Immunology, 1980
- Essential role for mevalonate synthesis in DNA replicationProceedings of the National Academy of Sciences, 1979
- Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor.Journal of Biological Chemistry, 1979
- Synthesis of ubiquinone and cholesterol in human fibroblasts: Regulation of a branched pathwayArchives of Biochemistry and Biophysics, 1979
- Inhibitory Effects on Lipid Metabolismn in Cultured Cells of ML‐236B, a Potent Inhibitor of 3‐Hydroxt‐3‐methylglutaryl‐Cornzyme‐A ReductaseEuropean Journal of Biochemistry, 1978
- Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactumJournal of the Chemical Society, Perkin Transactions 1, 1976
- Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development.The Journal of Experimental Medicine, 1975
- PURIFICATION OF MITOGENIC PROTEINS DERIVED FROM Phaseolus vulgaris : ISOLATION OF POTENT AND WEAK PHYTOHEMAGGLUTININS POSSESSING MITOGENIC ACTIVITYProceedings of the National Academy of Sciences, 1969
- Forms of human serum high density lipoprotein proteinJournal of Lipid Research, 1966